Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma

2009407 citationsJournal Articlebronze Open Access

Authors

Danit Lebanony · Israel Cancer Association

Hila Benjamin · Israel Cancer Association

Shlomit Gilad · Tel Aviv University

Meital Ezagouri · Medical Research Institute

Avital Dov · Rosetta Genomics (Israel)

Karin Ashkenazi · New York University

N. E. Gefen ·

Abstract

Hsa-miR-205 is a highly accurate marker for lung cancer of squamous histology. The standardized diagnostic assay presented here can provide highly accurate subclassification of NSCLC patients.

Topics & Keywords

MicroRNA in disease regulation Cancer-related molecular mechanisms research Molecular Biology Techniques and Applications

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 27, Issue 12, pp. 2030-2037

DOI: 10.1200/jco.2008.19.4134

Field-Weighted Citation Impact: 17.17